NATURALLY DERIVED COMPOUNDS USED FOR PREVENTION OR REGRESSION OF EXPERIMENTALLY INDUCED LIVER FIBROSIS

ANGIOGENESIS IN BOTH NORMAL AND PATHOLOGICAL DEVELOPMENT

Amelioration of Bile Duct Ligation Induced Liver Injury by Lactoferrin: Role of Nrf2/HO-1 Pathway

Chemotherapy-Induced Liver Injury: Unveiling Emerging Mechanisms and Exploring Mitigation Strategies

Pathophysiology of Cholestatic Liver Diseases: New Insights into the Mechanisms of Bile Infarct Formation

Potential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats

A DIHYDROCHALCONE AND SGLT2 INHIBITOR ABATE METHOTREXATE HEPATOTOXICITY IN MALE RATS; A COMPARATIVE STUDY

Cholestyramine Modulates Non-Alcoholic Steatohepatitis Induced by Methionine and Choline Deficiency in Rats: Cross-linking AGEs, MIP2, EMR1 and Adiponectin.

Mechanisms of Cyclosporin A Induced Hepatotoxicity

SILYMARIN AMELIORATES DIETHYLNITROSAMINE-INDUCED LIVER FIBROSIS IN WISTAR RATS